Related Experiment Video
Updated: Jun 15, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Advanced Interatrial block induced by flecainide
Jillian Hall1, Daniel Edmundowicz1, Edmond Cronin1
1Section of Cardiology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
Flecainide toxicity can cause advanced interatrial block, a serious heart conduction abnormality. This case highlights the critical need to monitor cardiac function during flecainide treatment.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Interatrial block is a delay in electrical conduction between the atria.
- Flecainide is an antiarrhythmic drug with potential proarrhythmic effects.
- Drug toxicity can manifest as novel conduction abnormalities.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Mechanism of Cardiac Arrhythmias

